BACKGROUND: The small, dense LDL phenotype is associated with an increased cardiovascular disease risk. A genome-wide scan performed on 236 nuclear families of the Quebec Family Study (QFS) revealed a quantitative trait locus (QTL) affecting LDL peak particle size (LDL-PPD) and density on the 17q21 region. This region contains the phosphatidylcholine transfer protein gene (PCTP). In the liver, phosphatidylcholine transfer protein binds specifically phosphatidylcholine suggesting a role for this protein in the formation of HDL and possibly VLDL phospholipid membranes. OBJECTIVES: To test the association between two coding polymorphisms (c.29A>C (Glu10Ala) and c.188G>A (Cys63Tyr)) in PCTP gene and the LDL-PPD. METHODS: LDL-PPD was measured by non-denaturating 2-16% polyacrylamide gradient gel electrophoresis on 623 QFS subjects. RESULTS: After adjustment for age and sex, carriers of the c.29C allele showed larger LDL-PPD than A/A homozygotes (p<0.05). These results remained significant when LDL-PPD was further adjusted for the effects of BMI and triglyceride levels (p<0.04). We also observed a three-fold lower risk of having the small (LDL-PPD <256A), dense LDL phenotype in subjects carrying the c.29C allele, when compared to A/A homozygotes (OR=0.35 (95% CI: 0.14-0.91; p=0.03)). CONCLUSION: PCTP gene variants are associated with LDL-PPD.
BACKGROUND: The small, dense LDL phenotype is associated with an increased cardiovascular disease risk. A genome-wide scan performed on 236 nuclear families of the Quebec Family Study (QFS) revealed a quantitative trait locus (QTL) affecting LDL peak particle size (LDL-PPD) and density on the 17q21 region. This region contains the phosphatidylcholine transfer protein gene (PCTP). In the liver, phosphatidylcholine transfer protein binds specifically phosphatidylcholine suggesting a role for this protein in the formation of HDL and possibly VLDL phospholipid membranes. OBJECTIVES: To test the association between two coding polymorphisms (c.29A>C (Glu10Ala) and c.188G>A (Cys63Tyr)) in PCTP gene and the LDL-PPD. METHODS:LDL-PPD was measured by non-denaturating 2-16% polyacrylamide gradient gel electrophoresis on 623 QFS subjects. RESULTS: After adjustment for age and sex, carriers of the c.29C allele showed larger LDL-PPD than A/A homozygotes (p<0.05). These results remained significant when LDL-PPD was further adjusted for the effects of BMI and triglyceride levels (p<0.04). We also observed a three-fold lower risk of having the small (LDL-PPD <256A), dense LDL phenotype in subjects carrying the c.29C allele, when compared to A/A homozygotes (OR=0.35 (95% CI: 0.14-0.91; p=0.03)). CONCLUSION:PCTP gene variants are associated with LDL-PPD.
Authors: Baran A Ersoy; Akansha Tarun; Katharine D'Aquino; Nancy J Hancer; Chinweike Ukomadu; Morris F White; Thomas Michel; Brendan D Manning; David E Cohen Journal: Sci Signal Date: 2013-07-30 Impact factor: 8.192
Authors: Ekaterina Y Shishova; Janis M Stoll; Baran A Ersoy; Sudeep Shrestha; Erez F Scapa; Yingxia Li; Michele W Niepel; Ya Su; Linda A Jelicks; Gregory L Stahl; Marcie A Glicksman; Roger Gutierrez-Juarez; Gregory D Cuny; David E Cohen Journal: Hepatology Date: 2011-06-23 Impact factor: 17.425
Authors: Neil Wagle; Jun Xian; Ekaterina Y Shishova; Jie Wei; Marcie A Glicksman; Gregory D Cuny; Ross L Stein; David E Cohen Journal: Anal Biochem Date: 2008-08-12 Impact factor: 3.365
Authors: Guangfen Mao; Natthapol Songdej; Deepak Voora; Lawrence E Goldfinger; Fabiola E Del Carpio-Cano; Rachel A Myers; A Koneti Rao Journal: Circulation Date: 2017-07-04 Impact factor: 29.690
Authors: Karen H Y Wong; Michal Levy-Sakin; Walfred Ma; Nina Gonzaludo; Angel C Y Mak; Dedeepya Vaka; Annie Poon; Catherine Chu; Richard Lao; Melek Balamir; Zoe Grenville; Nicolas Wong; John P Kane; Pui-Yan Kwok; Mary J Malloy; Clive R Pullinger Journal: Mol Genet Genomic Med Date: 2019-10-16 Impact factor: 2.183